Pediatrics

cystic fibrosis lungs
Pediatrics Sleep Pharmaceuticals

FDA Grants SPIRO-2101 CF Treatment Orphan Drug and Rare Pediatric Disease Designations 

Spirovant Sciences, a gene therapy company developing treatments and cures for genetic lung diseases including cystic fibrosis, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug and Rare Pediatric Disease Designations to its lead product candidate, SPIRO-2101, for the treatment of cystic fibrosis. SPIRO-2101, an inhaled […]

oxygen delivery
Pediatrics Respiratory

New Clinical Guideline on Home Oxygen for Children

The American Thoracic Society has developed a new clinical practice guideline for home oxygen therapy for children. The guideline appears in the Feb. 1 edition of the Society’s American Journal of Respiratory and Critical Care Medicine. “Home Oxygen Therapy for Children: An Official American Thoracic Society Clinical Practice Guideline”   makes specific recommendations […]